Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy-Reference-Cited by-同舟云学术

Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy

Published:2018-04 Issue:4 Volume:36 Page:161.e19-161.e30
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Chen Xin,Bernemann Christof,Tolkach Yuri,Heller Martina,Nientiedt Cathleen,Falkenstein Michael,Herpel Esther,Jenzer Maximilian,Grüllich Carsten,Jäger Dirk,Sültmann Holger,Duensing Anette,Perner Sven,Cronauer Marcus V.,Stephan Carsten,Debus Jürgen,Schrader Andres Jan,Kristiansen Glen,Hohenfellner Markus,Duensing Stefan

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference34 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients;Attard;Clin Cancer Res,2011

3. Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer;Perner;Oncotarget,2015

4. Androgen receptor signaling in prostate cancer;Culig;Cancer Metastasis Rev,2014

5. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023;Pharmacological Reviews;2023-08-16

2. Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression;The Journal of Pathology: Clinical Research;2023-04-18

3. ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis;BMC Cancer;2023-03-29

4. The positive relationship between androgen receptor splice variant-7 expression and the risk of castration-resistant prostate cancer: A cumulative analysis;Frontiers in Oncology;2023-02-14

5. Synthesis and biological activity of 21,22-cyclosteroids and their derivatives;Steroids;2022-12